Baker Arthur R. III 4

Accession 0001437749-21-003290

CIK 0001443669other

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 4:44 PM ET

Size

27.5 KB

Accession

0001437749-21-003290

Insider Transaction Report

Form 4

Period: 2021-02-16

Proto Labs IncPRLB

Baker Arthur R. III

Chief Technology Officer

Transactions

Exercise/Conversion
Common Stock
2021-02-16$60.96/sh+3,474$211,775→ 23,337 total
Exercise/Conversion
Common Stock
2021-02-16$58.35/sh+3,628$211,694→ 26,965 total
Sale
Common Stock
2021-02-16$181.09/sh−802$145,235→ 26,163 total
Sale
Common Stock
2021-02-16$182.81/sh−1,100$201,093→ 25,063 total
Sale
Common Stock
2021-02-16$183.69/sh−900$165,318→ 24,163 total
Sale
Common Stock
2021-02-16$184.85/sh−1,500$277,275→ 22,663 total
Sale
Common Stock
2021-02-16$185.66/sh−2,100$389,887→ 20,563 total
Sale
Common Stock
2021-02-16$186.82/sh−700$130,775→ 19,863 total
Sale
Common Stock
2021-02-16$196.26/sh−2,000$392,520→ 17,863 total
Tax Payment
Common Stock
2021-02-16$197.05/sh−1,087$214,193→ 16,776 total
Award
Common Stock
2021-02-16+4,212→ 20,988 total
Exercise/Conversion
Employee Stock Option (right to buy)
2021-02-16−3,474→ 1,737 total
Exercise: $60.96Exp: 2026-05-02→ Common Stock (3,474 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2021-02-16−3,628→ 907 total
Exercise: $58.35Exp: 2027-02-13→ Common Stock (3,628 underlying)
Award
Employee Stock Option (right to buy)
2021-02-16+3,442→ 3,442 total
Exercise: $180.46Exp: 2031-02-16→ Common Stock (3,442 underlying)

Footnotes (10)

[F1]Reflects the weighted average price of 802 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $180.85 to $181.76 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F10]The option vests as to 25% of the shares in four annual installments beginning on February 13, 2022.
[F2]Reflects the weighted average price of 1,100 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $182.19 to $183.17 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F3]Reflects the weighted average price of 900 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $183.34 to $184.21 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F4]Reflects the weighted average price of 1,500 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $184.35 to $185.33 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F5]Reflects the weighted average price of 2,100 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $185.37 to $186.21 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F6]Reflects the weighted average price of 700 shares of common stock of Proto Labs, Inc. sold by the reporting person on February 16, 2021 with sale prices ranging from $186.43 to $187.34 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F7]The option vests as to 20% of the shares in five annual installments beginning on May 4, 2017.
[F8]The option vests as to 20% of the shares in five annual installments beginning on February 13, 2018.
[F9]The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2022.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

Proto Labs Inc

CIK 0001443669

→

Entity typeother

Related Parties

filerCIK 0001536324

Filing Metadata

Form type: 4
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 4:44 PM ET
Size: 27.5 KB

View on SEC.gov